Boosting Heart Healing by Enhancing Blood Vessel Activity and Reducing Scarring

Jim Crocker
2nd December, 2024

Boosting Heart Healing by Enhancing Blood Vessel Activity and Reducing Scarring

Inactivation of the Vegfa decoy receptor flt1 enhances endothelial regeneration after heart injury in zebrafish, a key step in promoting overall cardiac repair, by increasing coronary revascularization (a–d′), endothelial cell proliferation (e–h), and endocardial expansion (i–l).

Image adapted from: Wang et al. / CC BY (Source)

Key Findings

  • The study from the Max Planck Institute found that deleting the VEGFR1 gene in zebrafish hearts significantly improved heart regeneration after injury
  • Zebrafish hearts without the VEGFR1 gene showed better blood vessel growth, increased heart cell proliferation, and less scarring
  • The beneficial effects of VEGFR1 deletion were dependent on VEGFA signaling, highlighting its crucial role in heart repair
Heart failure following acute myocardial infarction remains a leading cause of death, primarily due to the limited regenerative capacity of the adult human heart. Cardiomyocytes, the cells responsible for heart contraction, are largely non-proliferative in adults, which hampers the heart's ability to repair itself after injury. Recent research from the Max Planck Institute for Heart and Lung Research provides new insights into enhancing the heart's regenerative potential by manipulating vascular endothelial growth factor A (VEGFA) signaling[1]. VEGFA is a protein that promotes the growth of new blood vessels, a process known as angiogenesis. Previous attempts to use VEGFA as a therapeutic agent for heart disease have met with limited success. The new study takes a different approach by focusing on VEGFA bioavailability. Specifically, the researchers investigated the effects of deleting VEGFA's decoy receptor, VEGFR1 (also known as FLT1), in zebrafish hearts. This genetic modification aims to increase the physiological concentrations of VEGFA, thereby enhancing its beneficial effects. The study found that zebrafish hearts lacking the flt1 gene showed significant improvements in heart regeneration after injury. These hearts displayed enhanced coronary revascularization, increased endocardial expansion, and more pronounced cardiomyocyte dedifferentiation and proliferation. Additionally, these hearts exhibited decreased scarring, which is a major barrier to effective heart regeneration. Importantly, the beneficial effects of flt1 deletion were nullified when Vegfa signaling was suppressed, confirming the crucial role of VEGFA in these processes. To understand the underlying mechanisms, the researchers conducted transcriptomic analyses of the injured flt1 mutant hearts. They observed enhanced endothelial MAPK/ERK signaling and a downregulation of the transcription factor gene egr3. Further investigations revealed that egr3 is upregulated in the regenerating endocardium and that Egr3 promotes myofibroblast differentiation. Myofibroblasts are cells that contribute to fibrosis and scarring. Therefore, the downregulation of egr3 in flt1 mutants limits myofibroblast differentiation, creating a more favorable environment for cardiomyocyte replenishment after injury. This study builds on previous research that has explored the mechanisms of heart regeneration in different models. For instance, zebrafish are known for their remarkable ability to regenerate heart tissue without excessive fibrosis. A study showed that interleukin-11 (Il-11) and Stat3 signaling are crucial for this process, as they drive cellular reprogramming and limit fibrosis by antagonizing transforming growth factor–β (TGF-β) signaling[2]. The current study adds to this understanding by highlighting the role of VEGFA bioavailability in promoting heart regeneration through similar anti-fibrotic mechanisms. Moreover, the findings align with previous research on the role of the extracellular matrix (ECM) in heart regeneration. For example, agrin, a component of the neonatal ECM, has been shown to promote cardiomyocyte proliferation and cardiac repair in mice[3]. The current study's focus on VEGFA and its receptor VEGFR1 further underscores the importance of the microenvironment in facilitating heart regeneration. Additionally, the study ties into research on the inflammatory response to cardiac injury. It has been shown that a balanced inflammatory response is essential for effective heart repair and regeneration. In zebrafish, different macrophage subsets play distinct roles in scarring and scar removal, with pro-inflammatory macrophages promoting scar deposition and other subsets facilitating scar resolution[4]. The current study's findings on egr3 and myofibroblast differentiation add another layer to our understanding of how the inflammatory response can be modulated to enhance heart regeneration. In summary, the research from the Max Planck Institute for Heart and Lung Research provides compelling evidence that enhancing VEGFA bioavailability by deleting its decoy receptor VEGFR1 can significantly improve heart regeneration. This approach not only promotes angiogenesis and cardiomyocyte proliferation but also limits fibrosis by modulating the microenvironment and inflammatory response. These findings open new avenues for developing regenerative therapies for heart disease, potentially transforming the treatment landscape for patients suffering from heart failure.

GeneticsBiochemAnimal Science

References

Main Study

1) flt1 inactivation promotes zebrafish cardiac regeneration by enhancing endothelial activity and limiting the fibrotic response.

Published 1st December, 2024

https://doi.org/10.1242/dev.203028


Related Studies

2) Interleukin-11 signaling promotes cellular reprogramming and limits fibrotic scarring during tissue regeneration.

https://doi.org/10.1126/sciadv.abg6497


3) The extracellular matrix protein agrin promotes heart regeneration in mice.

https://doi.org/10.1038/nature22978


4) Specific macrophage populations promote both cardiac scar deposition and subsequent resolution in adult zebrafish.

https://doi.org/10.1093/cvr/cvz221



Related Articles

An unhandled error has occurred. Reload 🗙